$ANTX
AN2 Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Menlo Park, CA
ANTX chart
What traders are saying about $ANTX
Latest postsAN2 Therapeutics, Inc. news
- AN2 Therapeutics, Inc. (ANTX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- AN2 Therapeutics, Inc. Estimates – NASDAQ:ANTX
TradingView ·
- AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)
Yahoo Finance ·
- AN2 Therapeutics to Present Phase 2 Design for Epetraborole in Polycythemia Vera at the 18th International Congress on Myeloproliferative Neoplasms
Yahoo Finance ·
- AN2 Therapeutics to Participate at Upcoming November 2026 Investor Conferences
BioSpace ·
- AN2 Therapeutics to Participate at Upcoming Investor Conferences
Yahoo Finance ·
- GSK (LSE:GSK) Deepens Its Drug Pipeline Through Two Research Partnerships
Yahoo Finance ·
- GSK (LSE:GSK) The Latest Update Raises A Bigger Question
Yahoo Finance ·
- AN2 Therapeutics Announces Extension of Funding for Tuberculosis Research Collaboration with GSK
Yahoo Finance ·
- AN2 Therapeutics Presents Clinical and Translational Data Supporting Development of Epetraborole for Polycythemia Vera at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting
Yahoo Finance ·
- Nontuberculous Mycobacterial Infections Market to Showcase Growth at a CAGR of 12.6% During the Forecast Period (2026–2036), Driven by Rising Disease Burden and Emerging Therapies | DelveInsight
Yahoo Finance ·
- AN2 Therapeutics Appoints Cameron Trenor, M.D., as Chief Medical Officer
Yahoo Finance ·
AN2 Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$35.2M | -$51.3M | -$64.7M | -$41.0M |
| Diluted EPS | $-1.16 | $-1.72 | $-2.74 | $-2.79 |
| Total assets (year end) | $62.0M | $92.1M | $138.7M | $102.6M |
| Cash and equivalents (year end) | $19.9M | $21.4M | $15.6M | $27.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About AN2 Therapeutics, Inc.
- Ticker
- ANTX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Menlo Park, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1880438
Frequently asked questions
What exchange is AN2 Therapeutics, Inc. listed on?
AN2 Therapeutics, Inc. trades on the Nasdaq under the ticker symbol ANTX.
What industry is AN2 Therapeutics, Inc. in?
AN2 Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is AN2 Therapeutics, Inc. headquartered?
AN2 Therapeutics, Inc.'s business address on file with the SEC is in Menlo Park, CA.
When does AN2 Therapeutics, Inc.'s fiscal year end?
AN2 Therapeutics, Inc.'s fiscal year ends on December 31.